Li H, Song X, Liang Y, et al. Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990–2019: results from a global burden of disease study, 2019. BMC Public Health. 2022;22(1):2015. https://doi.org/10.1186/s12889-022-14403-2.

Article  PubMed  PubMed Central  Google Scholar 

Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–21. https://doi.org/10.1177/1747493019897870.

Article  PubMed  Google Scholar 

Chen MA. Multimorbidity in older adults with atrial fibrillation. Clin Geriatr Med. 2016;32(2):315–29. https://doi.org/10.1016/j.cger.2016.01.001.

Article  PubMed  Google Scholar 

Zhang J, Johnsen SP, Guo Y, et al. Epidemiology of atrial fibrillation: geographic/ecological risk factors, age, sex, genetics. Card Electrophysiol Clin. 2021;13(1):1–23. https://doi.org/10.1016/j.ccep.2020.10.010.

Article  PubMed  Google Scholar 

Kornej J, Borschel CS, Benjamin EJ, et al. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020;127(1):4–20. https://doi.org/10.1161/CIRCRESAHA.120.316340.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results [Internet]. Institute for Health Metrics and Evaluation (IHME). 2020. Available from: https://vizhub.healthdata.org/gbd-results/.

Burdett P, Lip GYH. Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):187–94. https://doi.org/10.1093/ehjqcco/qcaa093.

Article  PubMed  Google Scholar 

Proietti M, Romiti GF, Olshansky B, et al. Comprehensive management With the ABC (atrial fibrillation better care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial. J Am Heart Assoc. 2020;9(10): e014932. https://doi.org/10.1161/jaha.119.014932.

Article  PubMed  PubMed Central  Google Scholar 

Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018–22. https://doi.org/10.1056/NEJM198204293061703.

Article  CAS  PubMed  Google Scholar 

Alexander KP, Brouwer MA, Mulder H, et al. Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: insights from the ARISTOTLE trial. Am Heart J. 2019;208:123–31. https://doi.org/10.1016/j.ahj.2018.09.017.

Article  CAS  PubMed  Google Scholar 

LaMori JC, Gross HJ, Patel AA, et al. Burden of comorbidities among patients with atrial fibrillation. Value Health. 2011;14(3):A34-A.

Google Scholar 

Proietti M, Marzona I, Vannini T, et al. Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use. Mayo Clin Proc. 2019;94(12):2427–36. https://doi.org/10.1016/j.mayocp.2019.06.012.

Article  CAS  PubMed  Google Scholar 

Kozieł M, Simovic S, Pavlovic N, et al. Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey. Ann Med. 2021;53(1):17–25. https://doi.org/10.1080/07853890.2020.1799241.

Article  CAS  PubMed  Google Scholar 

Lip GYH, Genaidy A, Tran G, et al. Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms. Thromb Haemost. 2022;122(1):142–50. https://doi.org/10.1055/a-1467-2993.

Article  PubMed  Google Scholar 

Dalgaard F, Xu H, Matsouaka RA, et al. Management of atrial fibrillation in older patients by morbidity burden: insights from get with the guidelines-atrial fibrillation. J Am Heart Assoc. 2020;9(23): e017024. https://doi.org/10.1161/JAHA.120.017024.

Article  PubMed  PubMed Central  Google Scholar 

Romiti GF, Proietti M, Bonini N, et al. Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry Phase II and III. Thromb Haemost. 2022;122(12):2030–41. https://doi.org/10.1055/s-0042-1756355.

Article  PubMed  Google Scholar 

Gallagher C, Nyfort-Hansen K, Rowett D, et al. Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis. Open Heart. 2020. https://doi.org/10.1136/openhrt-2020-001257.

Article  PubMed  PubMed Central  Google Scholar 

Castillo-Páramo A, Clavería A, Verdejo González A, et al. Inappropriate prescribing according to the STOPP/START criteria in older people from a primary care setting. Eur J Gen Pract. 2014;20(4):281–9. https://doi.org/10.3109/13814788.2014.899349.

Article  PubMed  Google Scholar 

Alhawassi TM, Alatawi W, Alwhaibi M. Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria. BMC Geriatr. 2019. https://doi.org/10.1186/s12877-019-1168-1.

Article  PubMed  PubMed Central  Google Scholar 

Rothberg MB, Pekow PS, Liu F, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med. 2008;3(2):91–102. https://doi.org/10.1002/jhm.290.

Article  PubMed  Google Scholar 

O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52. https://doi.org/10.2165/11632610-000000000-00000.

Article  CAS  PubMed  Google Scholar 

Guaraldo L, Cano FG, Damasceno GS, et al. Inappropriate medication use among the elderly: a systematic review of administrative databases. BMC Geriatr. 2011. https://doi.org/10.1186/1471-2318-11-79.

Article  PubMed  PubMed Central  Google Scholar 

Lozano-Montoya I, Velez-Diaz-Pallares M, Delgado-Silveira E, et al. Potentially inappropriate prescribing detected by STOPP-START criteria: are they really inappropriate? Age Ageing. 2015;44(5):861–6. https://doi.org/10.1093/ageing/afv079.

Article  PubMed  Google Scholar 

Lucchetti G, Lucchetti AL. Inappropriate prescribing in older persons: a systematic review of medications available in different criteria. Arch Gerontol Geriatr. 2017;68:55–61. https://doi.org/10.1016/j.archger.2016.09.003.

Article  PubMed  Google Scholar 

Wallace E, McDowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271–7. https://doi.org/10.1093/gerona/glw140.

Article  PubMed  Google Scholar 

Tommelein E, Mehuys E, Petrovic M, et al. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–27. https://doi.org/10.1007/s00228-015-1954-4.

Article  PubMed  Google Scholar 

Panel BtAGSBCUE. American Geriatrics Society 2019 Updated AGS Beers Criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.

Article  Google Scholar 

O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8. https://doi.org/10.1093/ageing/afu145.

Article  PubMed  Google Scholar 

Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, et al. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study. PLoS ONE. 2020;15(8): e0237186. https://doi.org/10.1371/journal.pone.0237186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curtin D, Gallagher PF, O’Mahony D. Explicit criteria as clinical tools to minimize inappropriate medication use and its consequences. Ther Adv Drug Saf. 2019. https://doi.org/10.1177/2042098619829431.

Article  PubMed  PubMed Central  Google Scholar 

Hanlon JT, Schmader KE. The Medication Appropriateness Index: a clinimetric measure. Psychother Psychosom. 2022;91(2):78–83. https://doi.org/10.1159/000521699.

Article  PubMed  Google Scholar 

Grymonprez M, Steurbaut S, De Backer TL, et al. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. Front Pharmacol. 2020;11: 583311. https://doi.org/10.3389/fphar.2020.583311.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mekonnen AB, Redley B, de Courten B, et al. Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: a systematic review and meta-analysis. Br J Clin Pharmacol. 2021. https://doi.org/10.1111/bcp.14870.

Article  PubMed  Google Scholar 

Moudallel S, Steurbaut S, Cornu P, et al. Appropriateness of (D)OAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing. Front Pharmacol. 2018. https://doi.org/10.3389/fphar.2018.01220.

Article  PubMed  PubMed Central  Google Scholar 

Motter FR, Fritzen JS, Hilmer SN, et al. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74(6):679–700. https://doi.org/10.1007/s00228-018-2446-0.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. https://doi.org/10.1186/s13643-021-01626-4.